Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

OBJECTIVES: Mobility impairments constitute a long-term burden in patients with multiple sclerosis (MS). Currently there is evidence that the drug fampridine may improve nonwalking symptoms in MS patients. The main objective of this study is to analyze whether participants showing a beneficial walki...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Leal, Francisco Alejandro, Haase, Rocco, Akgün, Katja, Eisele, Judith, Proschmann, Undine, Schultheiss, Thorsten, Kern, Raimar, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475844/
https://www.ncbi.nlm.nih.gov/pubmed/31037211
http://dx.doi.org/10.1177/2040622319835136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475844/
https://www.ncbi.nlm.nih.gov/pubmed/31037211
http://dx.doi.org/10.1177/2040622319835136

Ejemplares similares